🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The hypotheses of the study are * There will be differences in perceived p...
Status
Completed
Location
University of Gujrat
Start Date
2023-08-15
Trial ID
NCT06001021
The purpose of this study is to compare the relative bioavailability of 3 m...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2005-09
Trial ID
NCT00865761
Treatments Being Tested
Patients will be divided into three groups. Group H patients will be given ...
Status
Unknown
Location
Multiple Locations
Start Date
2019-12-01
Trial ID
NCT04184141
Treatments Being Tested
To assess if the sublingual tablet will have similar pharmacokinetics as th...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-01
Trial ID
NCT01256151
Treatments Being Tested
To compare by neuroimaging techniques and public speaking, the way social a...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-03-27
Trial ID
NCT00555139
Treatments Being Tested
Phacoemulsification is one of the most used surgical methods for cataract s...
Status
Recruiting
Location
National Taiwan University Hospital
Start Date
2025-03-25
Trial ID
NCT06874452
Treatments Being Tested
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
Kendle International Inc.
Start Date
2004-08
Trial ID
NCT00647634
Treatments Being Tested
The objective of the study is to demonstrate the bioequivalence (BE) of alp...
Status
Completed
Location
Orion Pharma Phase I unit
Start Date
2009-05
Trial ID
NCT00878514
Treatments Being Tested
A study to investigate the effects GSK561679 on part of the body's system t...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-10-06
Trial ID
NCT00426608
Treatments Being Tested
Study to evaluate if Xanax sustained release tablets manufactured at two di...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-05
Trial ID
NCT01330472
Treatments Being Tested